Hong Kong approves Pfizer's 20-valent Pneumococcal Conjugate Vaccine for infants and children

American pharmaceutical firm Pfizer has announced that the Hong Kong Department of Health (DoH) has approved the company...

December 3, 2024 | Tuesday | News
Hong Kong lays focus on peptide drug innovation and discovery to pioneer collaboration in biopharma research

The University of Hong Kong (HKU), represented by Versitech Limited, has signed an agreement with China Merchants Group ...

November 30, 2024 | Saturday | News
Kingworld-Longde Life and Health Industrial Park opens in China

Kingworld Medicines Group has announced that the Group's Kingworld- Longde Life and Health Industrial Park in Bao&r...

November 28, 2024 | Thursday | News
Kingworld Medicines officiates operation at Kingworld-Longde Life and Health Industrial Park, in China

A leading healthcare distribution company, Kingworld Medicines Group Limited, has officially started operations at the K...

November 27, 2024 | Wednesday | News
VectorBuilder and Sartorius sign strategic cooperation agreement to advance biopharma innovation

VectorBuilder, a global leader in end-to-end gene delivery services, and Sartorius, a leading international partner in l...

November 27, 2024 | Wednesday | News
Zai Lab and Pfizer announce strategic collaboration for novel anti-bacterial drug XACDURO

China-based Zai Lab and American pharmaceutical firm Pfizer have announced a strategic collaboration for the novel anti-...

November 25, 2024 | Monday | News
China-based biotech startup Laekna teams up with Eli Lilly to develop obesity treatment

Laekna, Inc., a China-based biotech company focused on novel drug development for metabolic and cancer diseases, has ann...

November 21, 2024 | Thursday | News
Merck inks deal worth up to $2.7 B with Chinese biotech startup LaNova Medicines

Merck, known as MSD outside of the United States and Canada, and China-based biotech startup LaNova Medicines, have anno...

November 18, 2024 | Monday | News
Terumo Blood and Cell Technologies unlocks new chapter of localisation in China

Terumo Blood and Cell Technologies (Terumo BCT), recently held a localisation launch ceremony themed 'Unlocking a ...

November 15, 2024 | Friday | News
Chime Biologics and Waterstone team up to empower ADC development and manufacturing

China-based Chime Biologics, a leading global contract development and manufacturing organisation (CDMO) that enables it...

November 13, 2024 | Wednesday | News
Novotech and Biostar establish strategic partnership following Biostar’s HKEX listing

Novotech, the global full-service clinical Contract Research Organisation (CRO) that partners with biotech companies to ...

November 12, 2024 | Tuesday | News
Ping An Health and Medtronic form strategic partnership

China-based Ping An Healthcare and Technology has established a strategic partnership with Medtronic (Shanghai) Man...

November 11, 2024 | Monday | News
Trump’s Trade Tango Returns: Will China’s Biotech Dance Through Another Round of Tariffs or Stumble?

With Donald Trump’s return to the White House, the U.S.-China trade relationship is once again in the spotlight. T...

November 9, 2024 | Saturday | News
Hong Kong-based Insilico Medicine enters into revolving loan facility of up to $100 M with HSBC

Hong Kong-based Insilico Medicine, a global leading generative artificial intelligence (AI)-driven biotechnology company...

November 5, 2024 | Tuesday | News
Biosynth Biological Technology opens new state-of-the-art facility in China

Switzerland-headquartered Biosynth, a leading developer and supplier of critical raw materials and services for diagnost...

October 31, 2024 | Thursday | News
Korean startup Neurophet secures significant foothold to accelerate entry into China market

South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disease, has secured a s...

October 31, 2024 | Thursday | News
Hong Kong Innovation Center opens to provide one-stop support for early-stage drug discovery

ATLATL Hong Kong Innovation Center, a new state-of-the-art research facility designed to provide immediate, move-in-read...

October 30, 2024 | Wednesday | News
China's WuXi Biologics launches WuXia RidGS for non-antibiotic cell line development

China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...

October 29, 2024 | Tuesday | News